ciprofibrate has been researched along with sulfobromophthalein in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Foliot, A; Mallet, L; Touchard, D | 1 |
3 other study(ies) available for ciprofibrate and sulfobromophthalein
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Inhibition of liver glutathione S-transferase activity in rats by hypolipidemic drugs related or unrelated to clofibrate.
Topics: Animals; Bile; Cell Division; Clofibrate; Clofibric Acid; Fibric Acids; Glutathione Transferase; Hypolipidemic Agents; Liver; Male; Microbodies; Rats; Rats, Inbred Strains; Sulfobromophthalein | 1986 |